Literature DB >> 29543924

Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods.

Rafał Podgórski1,2, David Aebisher3, Monika Stompor1,2, Dominika Podgórska4, Artur Mazur5.   

Abstract

The aim of this paper is a straightforward presentation of the steroidogenesis process and the most common type of congenital adrenal hyperplasia (CAH) - 21-hydroxylase deficiency - as well as the analytical diagnostic methods that are used to recognize this disease. CAH is a family of common autosomal recessive disorders characterized by impaired adrenal cortisol biosynthesis with associated androgen excess due to a deficiency of one or more enzymes in the steroidogenesis process within the adrenal cortex. The most common and prototypical example of the CAH disorders group (90-95%) is caused by 21-hydroxylase deficiency. Less frequent types of CAH are 11β-hydroxylase deficiency (up to 8% of cases), 17α-hydroxylase deficiency, 3β-hydroxysteroid dehydrogenase deficiency, P450 oxidoreductase deficiency and StAR deficiencies. In the 21-hydroxylase and 11β-hydroxylase deficiency, only adrenal steroidogenesis is affected, whereas a defect in 3β-hydroxysteroid dehydrogenase or 17α-hydroxylase also involves gonadal steroid biosynthesis. Many countries have introduced newborn screening programs based on immunoassays measuring 17-hydroxyprogesterone from blood spots used for other neonatal screening tests which enable faster diagnosis and treatment of CAH. Currently, chromatographic techniques coupled with mass spectrometry are gaining popularity due to an increase in the reliability of the test results.

Entities:  

Keywords:  21-hydroxylase deficiency; CAH; Congenital Adrenal Hyperplasia; steroidogenesis

Mesh:

Substances:

Year:  2018        PMID: 29543924     DOI: 10.18388/abp.2017_2343

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  7 in total

1.  The prevalence of heterozygous CYP21A2 deficiency in patients with idiopathic acne, hirsutism, or both.

Authors:  Yinjie Gao; Bingqing Yu; Jiangfeng Mao; Xi Wang; Min Nie; Xueyan Wu
Journal:  Endocrine       Date:  2019-10-11       Impact factor: 3.633

2.  Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis.

Authors:  Viktoria Stachanow; Uta Neumann; Oliver Blankenstein; Davide Bindellini; Johanna Melin; Richard Ross; Martin J Whitaker; Wilhelm Huisinga; Robin Michelet; Charlotte Kloft
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

Review 3.  Assisted Reproduction in Congenital Adrenal Hyperplasia.

Authors:  Anastasios Chatziaggelou; Evangelos G Sakkas; Raffaella Votino; Maria Papagianni; George Mastorakos
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-23       Impact factor: 5.555

4.  Prevalence of nephrocalcinosis in children with congenital adrenal hyperplasia.

Authors:  Yahya Madihi; Neda Mostofizadeh; Hossein Shamsipour Dehkordi; Maryam Riahinezhad; Silva Hovsepian; Noushin Rostampour; Elham Hashemi Dehkodi; Mahryar Mehrkash; Tooba Momen; Mahin Hashemipour
Journal:  J Res Med Sci       Date:  2022-02-18       Impact factor: 1.852

5.  Congenital adrenal hyperplasia with homozygous and heterozygous mutations: a rare family case report.

Authors:  Tiantian Cheng; Jing Liu; Wenwen Sun; Guangyao Song; Huijuan Ma
Journal:  BMC Endocr Disord       Date:  2022-03-07       Impact factor: 2.763

6.  17 alpha-hydroxylase deficiency: A case report of young Chinese woman with a rare gene mutation.

Authors:  Li Hui Han; Liang Wang; Xiu Yun Wu
Journal:  Clin Case Rep       Date:  2022-07-25

7.  Genetic Testing for a Patient with Suspected 3 Beta-Hydroxysteroid Dehydrogenase Deficiency: A Case of Unreported Genetic Variants.

Authors:  Elisa Menegatti; Daniele Tessaris; Alice Barinotti; Patrizia Matarazzo; Silvia Einaudi
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.